GlassScriptPhysician profile
Frederic Elliot Liss
NPI 1447256680
$8,465.47
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,308 · 2020: $120 · 2021: $260 · 2022: $1,464 · 2023: $314.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $314.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $314.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $5,887.91 | 2019 | |
| Arthrex, INC. | $1,224.00 | 2022 | |
| Biedermann Motech, INC. | $175.36 | 2019 | |
| Smith+Nephew, INC. | $172.33 | 2019-2021 | |
| Trice Medical, INC. | $167.32 | 2023 | |
| Skeletal Dynamics INC | $132.07 | 2022 | |
| Paladin Technology Solutions | $126.42 | 2023 | |
| Depuy Synthes Sales INC. | $124.34 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $120.88 | 2021 | |
| Integra Lifesciences Corporation | $107.97 | 2022 | |
| Djo, LLC | $104.16 | 2019 | |
| Medartis INC. | $64.96 | 2019 | |
| Checkpoint Surgical, INC | $37.19 | 2019 | |
| Bioventus LLC | $20.56 | 2023 | Durolane |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frederic Liss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.